Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
16 studies found for:    agomelatine
Show Display Options
Rank Status Study
1 Completed Agomelatine in Depressed Patients With Fibromyalgia
Conditions: Major Depression;   Fibromyalgia
Intervention: Drug: agomelatine
2 Not yet recruiting Cardiovascular Effects of Agomelatine and Escitalopram in Patients With Major Depressive Disorder (MDD)
Condition: Major Depressive Disorder (MDD)
Interventions: Drug: Agomelatine;   Drug: Escitalopram
3 Completed A Placebo- and Paroxetine-controlled Study of the Efficacy, Safety and Tolerability of Agomelatine (25 or 50 mg) in the Treatment of Major Depressive Disorder (MDD)
Condition: Major Depressive Disorder
Interventions: Drug: Agomelatine;   Drug: paroxetine;   Drug: placebo
4 Unknown  Agomelatine Treatment of Depression in Schizophrenia (AGOPSYCH)
Conditions: Schizophrenia;   Schizophrenia-spectrum-disorders
Intervention: Drug: agomelatine
5 Completed Efficacy of Agomelatine in Patients With Obsessive-Compulsive Disorder
Condition: Obsessive Compulsive Disorder
Interventions: Drug: Agomelatine A;   Drug: Placebo
6 Completed Efficacy, Safety and Tolerability of Agomelatine Sublingual Tablets in the Treatment of Major Depressive Disorder
Condition: Major Depressive Disorder
Interventions: Drug: Agomelatine (AGO178C);   Drug: Placebo
7 Terminated Open-label Long Term (52 Weeks) Safety and Tolerability of Agomelatine Sublingual Tablets in Major Depressive Disorder (MDD)
Condition: Major Depressive Disorder
Intervention: Drug: AGO178
8 Completed Efficacy, Safety and Tolerability of Agomelatine Sublingual Tablets in the Treatment of Major Depressive Disorder (MDD)
Condition: Major Depressive Disorder
Interventions: Drug: Agomelatine (AGO178C);   Drug: Placebo
9 Completed
Has Results
A Study of Vortioxetine (Lu AA21004) in Comparison to Agomelatine in Adults Suffering From Major Depression With Inadequate Response to Previous Medication
Condition: Major Depressive Disorder
Interventions: Drug: Vortioxetine (Lu AA21004);   Drug: Agomelatine
10 Completed Pharmacokinetics of Agomelatine in Patients With Liver Impairment
Condition: Hepatic Impairment
Intervention: Drug: AGO178
11 Completed Efficacy, Safety and Tolerability of Agomelatine in the Prevention of Relapse of Major Depressive Disorder
Condition: Major Depressive Disorder
Interventions: Drug: agomelatine;   Drug: placebo
12 Completed Efficacy, Safety and Tolerability of Agomelatine in the Treatment of Major Depressive Disorder
Condition: Major Depressive Disorder
Interventions: Drug: agomelatine;   Drug: placebo
13 Completed Efficacy, Safety and Tolerability of Agomelatine in the Treatment of Major Depressive Disorder
Condition: Major Depressive Disorder (MDD)
Interventions: Drug: agomelatine;   Drug: placebo
14 Completed Pharmacokinetics, Safety and Tolerability of AGO178C in Subjects With Renal Deficiencies Compared With Healthy Subjects
Condition: Renal Impairment
Intervention: Drug: AGO178C
15 Withdrawn The Effect of Agomelatine or Fluoxentine on Heart Rate Variability in Patients With Major Depressive Disorder
Condition: Depressive Disorder, Major
Interventions: Drug: Agomelatine;   Drug: Fluoxentine
16 Recruiting Pharmacovigilance in Gerontopsychiatric Patients
Conditions: Dementia;   Depression;   Schizophrenia;   Psychosomatic Disorders;   Anxiety Disorders
Interventions: Drug: Phenobarbital;   Drug: Phenytoin;   Drug: Carbamazepine;   Drug: Oxcarbazepine;   Drug: Valproic Acid;   Drug: Lamotrigine;   Drug: Topiramate;   Drug: Gabapentin;   Drug: Levetiracetam;   Drug: Pregabalin;   Drug: Lacosamide;   Drug: Clonazepam;   Drug: Biperiden;   Drug: Levomepromazine;   Drug: Fluphenazine;   Drug: Perphenazine;   Drug: Perazine;   Drug: Thioridazine;   Drug: Haloperidol;   Drug: Melperone;   Drug: Pipamperone;   Drug: Bromperidol;   Drug: Benperidol;   Drug: Sertindole;   Drug: Ziprasidone;   Drug: Flupentixol;   Drug: Chlorprothixene;   Drug: Zuclopenthixol;   Drug: Fluspirilene;   Drug: Pimozide;   Drug: Clozapine;   Drug: Olanzapine;   Drug: Quetiapine;   Drug: Sulpiride;   Drug: Tiapride;   Drug: Amisulpride;   Drug: Prothipendyl;   Drug: Risperidone;   Drug: Aripiprazole;   Drug: Paliperidone;   Drug: Diazepam;   Drug: Oxazepam;   Drug: Lorazepam;   Drug: Bromazepam;   Drug: Clobazam;   Drug: Alprazolam;   Drug: Hydroxyzine;   Drug: Buspirone;   Drug: Chloral Hydrate;   Drug: Flurazepam;   Drug: Nitrazepam;   Drug: Triazolam;   Drug: Lormetazepam;   Drug: Temazepam;   Drug: Midazolam;   Drug: Brotizolam;   Drug: Zopiclone;   Drug: Zolpidem;   Drug: Zaleplon;   Drug: Melatonin;   Drug: Clomethiazole;   Drug: Diphenhydramine;   Drug: Promethazine;   Drug: Imipramine;   Drug: Clomipramine;   Drug: Opipramol;   Drug: Trimipramine;   Drug: Amitriptyline;   Drug: Nortriptyline;   Drug: Doxepin;   Drug: Maprotiline;   Drug: Amitriptyline oxide;   Drug: Fluoxetine;   Drug: Citalopram;   Drug: Paroxetine;   Drug: Sertraline;   Drug: Fluvoxamine;   Drug: Escitalopram;   Drug: Tranylcypromine;   Drug: Moclobemide;   Drug: Mianserin;   Drug: Trazodone;   Drug: Mirtazapine;   Drug: Bupropion;   Drug: Venlafaxine;   Drug: Reboxetine;   Drug: Duloxetine;   Drug: Agomelatine;   Drug: Pyritinol;   Drug: Piracetam;   Drug: Donepezil;   Drug: Rivastigmine;   Drug: Galantamine;   Drug: Memantine;   Drug: Nicergoline;   Drug: Acamprosate;   Drug: Lithium

Indicates status has not been verified in more than two years